These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 30616110)

  • 1. Injectable and biodegradable phospholipid-based phase separation gel for sustained delivery of insulin.
    Zhang T; Luo J; Peng Q; Dong J; Wang Y; Gong T; Zhang Z
    Colloids Surf B Biointerfaces; 2019 Apr; 176():194-201. PubMed ID: 30616110
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A high-efficiency, low-toxicity, phospholipids-based phase separation gel for long-term delivery of peptides.
    Zhang T; Peng Q; San FY; Luo JW; Wang MX; Wu WQ; Gong T; Zhang ZR
    Biomaterials; 2015 Mar; 45():1-9. PubMed ID: 25662489
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thymopentin-loaded phospholipid-based phase separation gel with long-lasting immunomodulatory effects: in vitro and in vivo studies.
    Zhang T; Qin XY; Cao X; Li WH; Gong T; Zhang ZR
    Acta Pharmacol Sin; 2019 Apr; 40(4):514-521. PubMed ID: 30002492
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetic and pharmacodynamic study of a phospholipid-based phase separation gel for once a month administration of octreotide.
    Wang M; Shan F; Zou Y; Sun X; Zhang ZR; Fu Y; Gong T
    J Control Release; 2016 May; 230():45-56. PubMed ID: 27040814
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Progesterone Phospholipid Gel for Intramuscular Administration Prepared by In Situ-Phase Separation.
    Dong N; Tang L; Zhao M; Zhang Y; Zhang Y; Yin T; He H; Gou J; Yuan Y; Tang X
    AAPS PharmSciTech; 2022 Nov; 23(8):294. PubMed ID: 36329305
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An injectable, low-toxicity phospholipid-based phase separation gel that induces strong and persistent immune responses in mice.
    Han L; Xue J; Wang L; Peng K; Zhang Z; Gong T; Sun X
    Biomaterials; 2016 Oct; 105():185-194. PubMed ID: 27522253
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In situ Preparation of a Phospholipid Gel Co-Loaded with Methotrexate and Dexamethasone for Synergistic Rheumatoid Arthritis Treatment.
    Pu Q; Wang K; Peng B; Chen K; Gong T; Liu F; Yang Q
    Int J Nanomedicine; 2022; 17():5153-5162. PubMed ID: 36348765
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro and in vivo sustained release of exenatide from vesicular phospholipid gels for type II diabetes.
    Zhang Y; Zhong Y; Hu M; Xiang N; Fu Y; Gong T; Zhang Z
    Drug Dev Ind Pharm; 2016; 42(7):1042-9. PubMed ID: 26558908
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-Acting Phospholipid Gel of Exenatide for Long-Term Therapy of Type II Diabetes.
    Hu M; Zhang Y; Xiang N; Zhong Y; Gong T; Zhang ZR; Fu Y
    Pharm Res; 2016 Jun; 33(6):1318-26. PubMed ID: 26857900
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Injectable and biodegradable thermosensitive hydrogels loaded with PHBHHx nanoparticles for the sustained and controlled release of insulin.
    Peng Q; Sun X; Gong T; Wu CY; Zhang T; Tan J; Zhang ZR
    Acta Biomater; 2013 Feb; 9(2):5063-9. PubMed ID: 23036950
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The implantable and biodegradable PHBHHx 3D scaffolds loaded with protein-phospholipid complex for sustained delivery of proteins.
    Peng Q; Yang YJ; Zhang T; Wu CY; Yang Q; Sun X; Gong T; Zhang L; Zhang ZR
    Pharm Res; 2013 Apr; 30(4):1077-85. PubMed ID: 23224980
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhanced anti-tumor and anti-metastasis efficacy against breast cancer with an intratumoral injectable phospholipids-based phase separation gel co-loaded with 5-fluotouracil and magnesium oxide by neutralizing acidic microenvironment.
    Yang L; Song X; Gong T; Wang L; Zhao T; Li L; Zhou C; Sun X; Zhang Z; Gong T
    Int J Pharm; 2018 Aug; 547(1-2):181-189. PubMed ID: 29864512
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Controlled delivery of basal insulin from phase-sensitive polymeric systems after subcutaneous administration: in vitro release, stability, biocompatibility, in vivo absorption, and bioactivity of insulin.
    Al-Tahami K; Oak M; Singh J
    J Pharm Sci; 2011 Jun; 100(6):2161-71. PubMed ID: 21491440
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preparation and evaluation of injectable Rasagiline mesylate dual-controlled drug delivery system for the treatment of Parkinson's disease.
    Jiang Y; Zhang X; Mu H; Hua H; Duan D; Yan X; Wang Y; Meng Q; Lu X; Wang A; Liu W; Li Y; Sun K
    Drug Deliv; 2018 Nov; 25(1):143-152. PubMed ID: 29275639
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preparation and in vivo evaluation of insulin-loaded biodegradable nanoparticles prepared from diblock copolymers of PLGA and PEG.
    Haggag Y; Abdel-Wahab Y; Ojo O; Osman M; El-Gizawy S; El-Tanani M; Faheem A; McCarron P
    Int J Pharm; 2016 Feb; 499(1-2):236-246. PubMed ID: 26746800
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhancing thermal stability of a highly concentrated insulin formulation with Pluronic F-127 for long-term use in microfabricated implantable devices.
    Li J; Chu MK; Lu B; Mirzaie S; Chen K; Gordijo CR; Plettenburg O; Giacca A; Wu XY
    Drug Deliv Transl Res; 2017 Aug; 7(4):529-543. PubMed ID: 28429276
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A sustained-release phospholipid-based phase separation gel loaded with berberine for treating rheumatoid arthritis.
    Peng X; Yang Y; Guo C; He Q; Li Y; Gong T; Li J
    Front Pharmacol; 2023; 14():1210129. PubMed ID: 37547331
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Injectable insulin-lysozyme-loaded nanogels with enzymatically-controlled degradation and release for basal insulin treatment: In vitro characterization and in vivo observation.
    Chou HS; Larsson M; Hsiao MH; Chen YC; Röding M; Nydén M; Liu DM
    J Control Release; 2016 Feb; 224():33-42. PubMed ID: 26723525
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development and evaluation of in situ gel-forming system for sustained delivery of insulin.
    Dhawan S; Kapil R; Kapoor DN
    J Biomater Appl; 2011 Mar; 25(7):699-720. PubMed ID: 20207780
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An injectable particle-hydrogel hybrid system for glucose-regulatory insulin delivery.
    Zhao F; Wu D; Yao D; Guo R; Wang W; Dong A; Kong D; Zhang J
    Acta Biomater; 2017 Dec; 64():334-345. PubMed ID: 28974477
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.